Share
Could one daily pill extend your loyal canine’s life? That’s what this trial hopes to find out, and it’s looking for more participants.
CARRROLLTON, Texas – A clinical trial is underway in North Texas to see if a new drug can effectively extend the life of older dogs.
The drug was created by a biotech company called Loyal and is the first of its kind to be up for FDA approval.
The STAY study is enrolling 1,000 senior dogs across the country. The goal is to see if a new medication up for FDA approval can extend a dog's healthy lifespan.
At Advanced Care Veterinary Services in Carrollton, Bella went in for a check-up on Wednesday.
The 13-year-old chocolate lab is part of a comprehensive clinical trial aimed at extending a dog's life by interrupting its metabolic dysfunction, which causes aging.
Featured
In a statement, a city spokesperson says the shelter manager was fired after they became aware of "misrepresentations made on her employment application and during a subsequent interview."
Dr. Douglas Stramel is one of 70 veterinarians taking part in a nationwide clinical trial launched by Loyal, a biotech company.
"The product that we're using actually slows that pathway," he explained. "So we're actually destroying the metabolic dysfunction, allowing the metabolism to work better, longer."
The Stay Study is enrolling 1,000 dogs. It's a double-blind study, which means neither the vet nor the owner knows if the dog is getting the actual medication or a placebo.
"We want to make sure that it's a healthy lifestyle, and we can prolong it as much as possible," Dr. Stramel said.
Enrolled dogs take one pill per day, and all costs are covered by the company. The four-year study is the final step needed for Loyal to submit the medication for FDA approval.
Kenny Coomes is Bella's owner.
"They just don't live long enough," he said. "So anything we can do to help possibly to extend the lives of other dogs, that’s where we want to be."
Featured
This Dallas pup was in such bad shape when he was picked up that he could barely walk or see. Take a look at him now!
Since starting the clinical trial, Coomes says Bella appears to have more energy.
"Whenever she's running through the fields, she's just the happiest. That's where she needs to be," he said.
In order to enroll, a dog must:
Extending a pet's life can be controversial in cases where the animal is already suffering.
In this trial, dogs with certain medical conditions — such as cancer, severe heart issues and diabetes — will be excluded.
There's no telling if Bella is actually feeling good due to the medication or if it’s simply the result of the placebo effect.
Regardless, Coomes is just grateful for a shot at having Bella around for a few more years.
Featured
The FOX LOCAL app is your source for live FOX 4 news, top stories, Dallas-Fort Worth weather updates, and more local and national coverage, plus 24/7 streaming coverage from across the nation. Here’s how to download.
"If we get lucky, and she gets the drug, and it works, then that's good. If not, maybe we help somebody else," he said. "The longer she's alive, the happier I am."
More information on Loyal’s clinical trial can be found here: loyal.com/clinical-trials
Information in this article comes from Loyal Biotech Company and interviews with a Carrollton veterinarian and a trial participant.
All the news you need to know, every day
By clicking Sign Up, I confirm
that I have read and agree
to the Privacy Policy
and Terms of Service.
This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX Television Stations
